Press Releases
-
February 14, 2022
Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results
2021 Total Product Bookings of $1.217 billion Full Year 2021 Revenues of $1.132 billion Ended Year with 151 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems Entered 2022 with Product Backlog of $1.254 billion Omnicell, Inc....
-
January 05, 2022
Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full-year 2021, after market on Monday,...
-
January 04, 2022
Omnicell Acquires MarkeTouch Media
Strategic acquisition of pharmacy technology solutions provider expands and deepens EnlivenHealth division’s footprint across key pharmacy segments Accelerates Software-as-a-Service (“SaaS”) technology roadmap Omnicell, Inc. (Nasdaq:OMCL), a leading...
-
December 29, 2021
Omnicell Completes Acquisition of ReCept
Addition of specialty pharmacy management services expands Advanced Services portfolio to support access to and management of complex medications Expected to be accretive to Omnicell’s non-GAAP EBITDA first quarter of 2023 Omnicell, Inc....
-
December 02, 2021
Omnicell to Acquire ReCept
Strategic acquisition of leading specialty pharmacy management services provider supports the Autonomous Pharmacy vision and expands Omnicell’s Advanced Services portfolio Addresses significant need for access to and management of complex...
-
November 22, 2021
Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conferences: Randall Lipps, Omnicell Chairman,...
-
November 10, 2021
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals
Automated Controlled Substance Dispenser to accommodate Fresenius Kabi Simplist® MicroVault® Pre-filled Syringes Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and...
-
November 02, 2021
Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
First Veterans Affairs facility to implement automation and technology-enabled services to support more cost-effective workflows and enhance pharmacy operations Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of...
-
November 02, 2021
Omnicell Announces Financial Results for Third Quarter 2021
GAAP and non-GAAP revenues of $296 million GAAP net income per diluted share of $0.61 Non-GAAP net income per diluted share of $1.08 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of...
-
October 11, 2021
Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter of 2021 before the open of the market on Tuesday,...
-
September 09, 2021
Omnicell Completes Acquisition of FDS Amplicare
Expands nationwide footprint of retail pharmacy customers, adding industry-leading financial management, analytics, and population health solutions to EnlivenHealth division offering Addition of SaaS solutions accelerates EnlivenHealth’s innovation...
-
September 06, 2021
Omnicell Grows International Footprint with Opening of Omnicell India Software Development Center
Access to expanded engineering resources will accelerate innovation for the Company’s cloud-based solutions portfolio Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and...
-
August 18, 2021
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release
New capabilities focus on superior customer experience and innovation to drive maximum value sooner; deliver improved workflow efficiency, expanded automation, and enhanced medication management intelligence Omnicell, Inc. (Nasdaq:OMCL), a leading...
-
July 29, 2021
Spartanburg Regional Healthcare System Partners with Omnicell to Drive Improved Clinical and Operational Outcomes
End-to-End Medication Management Platform Fulfills Journey to Fully Autonomous Pharmacy Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that...
-
July 29, 2021
Omnicell Announces Financial Results for Second Quarter 2021
Record revenues of $273 million GAAP net income per diluted share of $0.43 Record non-GAAP net income per diluted share of $0.97 Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare...
-
July 26, 2021
Omnicell to Acquire FDS Amplicare
Strategic acquisition of leading pharmacy SaaS solutions provider supports the Autonomous Pharmacy vision and expands Omnicell’s Advanced Services portfolio Accelerates innovation roadmap for EnlivenHealth division with addition of SaaS solutions...